On Jan. 14, 2026, the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) jointly released the “Guiding Principles of Good AI Practice in Drug Development,” a set of 10 high-level principles intended to steer the safe and responsible use of AI across the product lifecycle. While not formal industry guidance, the
Healthcare & Life Sciences Private Equity Deal Tracker: Water Street Acquires Pillr From Renovus
Water Street Healthcare Partners has acquired Pillr Health from Renovus Capital Partners, according to a news release.
Pillr, founded in 2003 and based in Boca Raton, Florida, is a provider of software and tech-enabled pharmacy solutions.
Water Street, founded in 2005 and based in Chicago, is a private equity firm focused exclusively…
New Mountain Closes New Fund With $1.2 Billion
By Trey Andrews
New Mountain Capital announced the closing of its second non-control private equity fund.
The fund, New Mountain Strategic Equity Fund II, closed at $1.2 billion, exceeding its hard cap of $1 billion.
New Mountain, founded in 1999 and based in New York, is a growth-oriented investment firm. Areas of focus for the firm include…
DoW Announces Line-by-Line Review of Certain 8(a) Contracts Amid Government-wide Scrutiny of the 8(a) Program
On January 16, 2026, the Secretary of War Pete Hegseth posted a video on social media announcing that the Department of War will conduct a “line‑by‑line review of every small business, sole source, 8(a) contract that is over $20 million,” focusing on impermissible pass‑throughs to large businesses. This action by the DoW aligns with broader federal investigations and audits of the 8(a) program.
Healthcare & Life Sciences Private Equity Deal Tracker: Lead Capital Invests in PedsOne
Lead Capital Partners (LCP) has announced an investment in PedsOne.
PedsOne, founded in 2011 and based in Nashville, Tennessee, is a provider of outsourced revenue cycle management and consulting services to independent pediatric practices throughout the United States.
LCP, founded in 2011 and based in Nashville, Tennessee, is a lower middle market private…
Healthcare & Life Sciences Private Equity Deal Tracker: WindRose Invests in Avalon Healthcare
WindRose Health Investors has announced an investment in Avalon Healthcare Solutions.
Avalon, founded in 2013 and based in Tampa, Florida, is a healthcare technology company that manages the appropriate use of routine and genetic diagnostic laboratory tests on behalf of health plan clients.
WindRose, founded in 2000 and based in New York, pursues…
Healthcare & Life Sciences Private Equity Deal Tracker: Eir Partners Closes New Fund With $1 Billion
Eir Partners Capital announced the closing of its third fund.
The fund, Eir Partners III, closed with aggregate capital commitments of $1 billion, exceeding its target of $800 million.
Eir, founded in 2015 and based in Miami, is a middle market private equity firm focused on healthcare technology and tech-enabled services. Eir’s targeted stages…
Healthcare & Life Sciences Private Equity Deal Tracker: Veritas to Acquire GHX
By Trey Andrews
Veritas Capital announced one of its affiliates will acquire a majority stake in Global Healthcare Exchange (GHX).
GHX, founded in 2000 and based in Louisville, Colorado, is a supply chain software platform.
Veritas, founded in 1992 and based in New York, is a private equity firm that primarily targets technology or technology-enabled solutions…
Creation of DOJ Fraud Division Signals Increased White-Collar Enforcement
On Jan. 8, 2026, the White House announced the establishment of the DOJ’s Division for National Fraud Enforcement. The Trump administration stated that the new division will “combat the rampant and pervasive problem of fraud in the United States” and “enforce the Federal criminal and civil laws against fraud targeting Federal government programs, Federally funded…
Lindsay Goldberg Closes New Fund With $4.9 Billion
Lindsay Goldberg announced the closing of its sixth fund.
The fund, Lindsay Goldberg VI, closed with $4.9 billion, surpassing its target of $4.0 billion.
Lindsay Goldberg, founded in 2001 and based in New York, is a private investment firm focused on healthcare, industrials and services. Since its founding in 2001, the firm has raised…